A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening

Gita V. Soraya, Thanh C. Nguyen, Chathurika D. Abeyrathne, Duc H. Huynh, Jianxiong Chan, Phuong D. Nguyen, Babak Nasr, Gursharan Chana, Patrick Kwan, Efstratios Skafidas

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

The early detection of colorectal cancer is vital for disease management and patient survival. Fecal hemoglobin detection is a widely-adopted method for screening and early diagnosis. Fecal Immunochemical Test (FIT) is favored over the older generation chemical based Fecal Occult Blood Test (FOBT) as it does not require dietary or drug restrictions, and is specific to human blood from the lower digestive tract. To date, no quantitative FIT platforms are available for use in the point-of-care setting. Here, we report proof of principle data of a novel low cost quantitative fecal immunochemical-based biosensor platform that may be further developed into a point-of-care test in low-resource settings. The label-free prototype has a lower limit of detection (LOD) of 10 μg hemoglobin per gram (Hb/g) of feces, comparable to that of conventional laboratory based quantitative FIT diagnostic systems.

Original languageEnglish
Article number19
Number of pages11
JournalBiosensors
Volume7
Issue number2
DOIs
Publication statusPublished - 1 May 2017
Externally publishedYes

Keywords

  • Biosensors
  • Colorectal cancer
  • Diagnostics
  • Immunosensor
  • Impedance
  • Interdigitated electrodes
  • Label-free
  • Point of care
  • Screening

Cite this

Soraya, G. V., Nguyen, T. C., Abeyrathne, C. D., Huynh, D. H., Chan, J., Nguyen, P. D., ... Skafidas, E. (2017). A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening. Biosensors, 7(2), [19]. https://doi.org/10.3390/bios7020019
Soraya, Gita V. ; Nguyen, Thanh C. ; Abeyrathne, Chathurika D. ; Huynh, Duc H. ; Chan, Jianxiong ; Nguyen, Phuong D. ; Nasr, Babak ; Chana, Gursharan ; Kwan, Patrick ; Skafidas, Efstratios. / A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening. In: Biosensors. 2017 ; Vol. 7, No. 2.
@article{b75c157d2a684a039881306f0f281e29,
title = "A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening",
abstract = "The early detection of colorectal cancer is vital for disease management and patient survival. Fecal hemoglobin detection is a widely-adopted method for screening and early diagnosis. Fecal Immunochemical Test (FIT) is favored over the older generation chemical based Fecal Occult Blood Test (FOBT) as it does not require dietary or drug restrictions, and is specific to human blood from the lower digestive tract. To date, no quantitative FIT platforms are available for use in the point-of-care setting. Here, we report proof of principle data of a novel low cost quantitative fecal immunochemical-based biosensor platform that may be further developed into a point-of-care test in low-resource settings. The label-free prototype has a lower limit of detection (LOD) of 10 μg hemoglobin per gram (Hb/g) of feces, comparable to that of conventional laboratory based quantitative FIT diagnostic systems.",
keywords = "Biosensors, Colorectal cancer, Diagnostics, Immunosensor, Impedance, Interdigitated electrodes, Label-free, Point of care, Screening",
author = "Soraya, {Gita V.} and Nguyen, {Thanh C.} and Abeyrathne, {Chathurika D.} and Huynh, {Duc H.} and Jianxiong Chan and Nguyen, {Phuong D.} and Babak Nasr and Gursharan Chana and Patrick Kwan and Efstratios Skafidas",
year = "2017",
month = "5",
day = "1",
doi = "10.3390/bios7020019",
language = "English",
volume = "7",
journal = "Biosensors",
issn = "2079-6374",
publisher = "MDPI AG",
number = "2",

}

Soraya, GV, Nguyen, TC, Abeyrathne, CD, Huynh, DH, Chan, J, Nguyen, PD, Nasr, B, Chana, G, Kwan, P & Skafidas, E 2017, 'A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening', Biosensors, vol. 7, no. 2, 19. https://doi.org/10.3390/bios7020019

A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening. / Soraya, Gita V.; Nguyen, Thanh C.; Abeyrathne, Chathurika D.; Huynh, Duc H.; Chan, Jianxiong; Nguyen, Phuong D.; Nasr, Babak; Chana, Gursharan; Kwan, Patrick; Skafidas, Efstratios.

In: Biosensors, Vol. 7, No. 2, 19, 01.05.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A label-free, quantitative Fecal Hemoglobin detection platform for colorectal cancer screening

AU - Soraya, Gita V.

AU - Nguyen, Thanh C.

AU - Abeyrathne, Chathurika D.

AU - Huynh, Duc H.

AU - Chan, Jianxiong

AU - Nguyen, Phuong D.

AU - Nasr, Babak

AU - Chana, Gursharan

AU - Kwan, Patrick

AU - Skafidas, Efstratios

PY - 2017/5/1

Y1 - 2017/5/1

N2 - The early detection of colorectal cancer is vital for disease management and patient survival. Fecal hemoglobin detection is a widely-adopted method for screening and early diagnosis. Fecal Immunochemical Test (FIT) is favored over the older generation chemical based Fecal Occult Blood Test (FOBT) as it does not require dietary or drug restrictions, and is specific to human blood from the lower digestive tract. To date, no quantitative FIT platforms are available for use in the point-of-care setting. Here, we report proof of principle data of a novel low cost quantitative fecal immunochemical-based biosensor platform that may be further developed into a point-of-care test in low-resource settings. The label-free prototype has a lower limit of detection (LOD) of 10 μg hemoglobin per gram (Hb/g) of feces, comparable to that of conventional laboratory based quantitative FIT diagnostic systems.

AB - The early detection of colorectal cancer is vital for disease management and patient survival. Fecal hemoglobin detection is a widely-adopted method for screening and early diagnosis. Fecal Immunochemical Test (FIT) is favored over the older generation chemical based Fecal Occult Blood Test (FOBT) as it does not require dietary or drug restrictions, and is specific to human blood from the lower digestive tract. To date, no quantitative FIT platforms are available for use in the point-of-care setting. Here, we report proof of principle data of a novel low cost quantitative fecal immunochemical-based biosensor platform that may be further developed into a point-of-care test in low-resource settings. The label-free prototype has a lower limit of detection (LOD) of 10 μg hemoglobin per gram (Hb/g) of feces, comparable to that of conventional laboratory based quantitative FIT diagnostic systems.

KW - Biosensors

KW - Colorectal cancer

KW - Diagnostics

KW - Immunosensor

KW - Impedance

KW - Interdigitated electrodes

KW - Label-free

KW - Point of care

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85020039573&partnerID=8YFLogxK

U2 - 10.3390/bios7020019

DO - 10.3390/bios7020019

M3 - Article

VL - 7

JO - Biosensors

JF - Biosensors

SN - 2079-6374

IS - 2

M1 - 19

ER -